Skip to content

Author

Banshi Saboo

We have 3 of 35 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Burden and Risk of Depression in Patients Receiving Semaglutide: A Systematic Review and Meta-Analysis.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide, are widely used for Type 2 diabetes mellitus (T2DM), obesity and related metabolic conditions. Evidence on potential neuropsychiatric effects remains inconsistent. This systematic review and meta-analysis evaluated depression risk among patien...

Gaurab Bhaduri, Shilanjan Roy, Anchin Kalia et al. · 0 citations
Clinical trial Open access Aug 2026

Clinical outcomes of a digitally delivered structured lifestyle program in type 2 diabetes: a randomized controlled trial from India

These findings support integrating structured, coach guided digital lifestyle programs into routine T2D care, particularly in resource limited, real-world settings such as India.

Chhavi G. Mehra, A. M. Raymond, Banshi Saboo et al. · 0 citations
Open access Aug 2026

Metabolic and clinical markers of T2D in obese Indians: an age-sex matched case-control study

This study identified and temporally validated key metabolic and clinical markers associated with prevalent T2D in obese Indians using age- and sex-matched case-control analysis and demonstrated good discrimination in obese Indian individuals.

Anagha Vyawahare, Pramod Tripathi, Nidhi Kadam et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.